Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...

CRISPR Therapeutics stays a Hold as CASGEVY launch lags; watch cash burn, revenue delays, and CTX310/CTX611 catalysts for ...

Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...

Today’s Forbes Daily also covers Anthropic’s hot streak, a junk bond master, Les Wexner’s upcoming Epstein deposition, cutting edge bobsled engineering and more.

Study in Science Advances shows proprietary Spherical Nucleic Acid (SNA) vaccine platform slows tumor growth and extends survival in preclinical models of HPV-related cancerEVANSTON, Ill.--(BUSINESS ...

ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...

CRISPR Therapeutics AG CRSP on Friday reported its fourth-quarter and full-year 2025 financial results, highlighting continued clinical progress, expanding uptake of Casgevy, and momentum across its ...

Scribe Therapeutics, Inc. (Scribe), a biotechnology company pioneering highly engineered CRISPR technologies designed to reshape the treatment of disease by enabling earlier intervention, improved ...

Oral diseases are a significant global health issue, affecting both quality of life and overall systemic health. Animal ...

The Vilcek Foundation is now accepting applications for the 2027 Vilcek Prizes for Creative Promise in Biomedical Science through May 4, 2026. These $50,000 cash awards are given each year to three ...

A novel CRISPR-based technology can spread within bacterial populations to eliminate antibiotic resistance.

CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As we ...